Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Myelodysplastic Syndromes 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Kidney Neoplasms 1Glioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Burkitt Lymphoma 1

Interventions

venetoclax 46Azacitidine 35Specimen Handling 34Cytarabine 31Biopsy 23fludarabine 22Cyclophosphamide 18decitabine and cedazuridine drug combination 14Injections 14Daunorubicin 14fludarabine phosphate 12Whole-Body Irradiation 11Busulfan 11Mycophenolic Acid 10Melphalan 10Tacrolimus 9Idarubicin 9CPX-351 9ivosidenib 8Stem Cell Transplantation 8Granulocyte Colony-Stimulating Factor 8Gemtuzumab 7Decitabine 7Cyclosporine 7enasidenib 6X-Rays 6Magnetic Resonance Spectroscopy 6Filgrastim 6gilteritinib 5Sirolimus 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Acute × Blood Component Removal × 30 days × Clear all
NCT06928662 2026-05-15

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
36 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡